Anavex Lf SC (AVXL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
9.50 -0.13 (-1.35%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 9.41 -0.09 (-0.95%) 18:45 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | AVXL | VIR | BCAX | ||
| Company | Anavex Lf SC | Vir Biotechnology Inc | Bicara Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.40 | 5.89 | 14.51 | ||
| High | 9.69 | 6.17 | 15.34 | ||
| Low | 9.33 | 5.83 | 13.28 | ||
| Last | 9.50 | 6.12 | 14.37 | ||
| Change | -0.13 | +0.14 | -0.51 | ||
| % Change | -1.35% | +2.34% | -3.43% | ||
| Volume | 639,400 | 925,000 | 584,000 | ||
| 20-Day Average Volume | 939,300 | 1,149,505 | 537,755 | ||
| Previous Close | 9.63 | 5.98 | 14.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.88 | 5.77 | 12.44 | ||
| 20-Day Raw Stochastic | 88.19% | 72.22% | 74.69% | ||
| 20-Day Relative Strength | 54.96% | 45.01% | 55.47% | ||
| Weighted Alpha | +42.15 | -61.11 | -35.68 | ||
| Today's Opinion | 72% Buy | 88% Sell | N/A | ||
| Previous Opinion | 56% Buy | 88% Sell | N/A | ||
| Last Month's Opinion | 16% Buy | 40% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 04/23/25 | +2.51% since 04/23/25 | -7.35% since 04/23/25 | ||
| Low | 9.27 on 04/24/25 | 5.83 on 04/30/25 | 13.28 on 04/30/25 | ||
| High | 9.72 on 04/28/25 | 6.30 on 04/28/25 | 15.78 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +8.94% since 03/28/25 | -8.66% since 03/28/25 | +7.24% since 03/28/25 | ||
| Low | 7.26 on 04/09/25 | 4.95 on 04/09/25 | 8.91 on 04/09/25 | ||
| High | 9.80 on 04/23/25 | 6.65 on 04/01/25 | 16.22 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -0.73% since 01/30/25 | -40.64% since 01/30/25 | +11.31% since 01/30/25 | ||
| Low | 7.26 on 04/09/25 | 4.95 on 04/09/25 | 8.91 on 04/09/25 | ||
| High | 10.20 on 03/20/25 | 10.67 on 02/06/25 | 16.68 on 03/07/25 | ||
| 6-Month | |||||
| %Chg | +66.37% since 10/30/24 | -19.47% since 10/30/24 | -39.37% since 10/30/24 | ||
| Low | 5.87 on 10/31/24 | 4.95 on 04/09/25 | 8.91 on 04/09/25 | ||
| High | 14.44 on 12/26/24 | 14.45 on 01/08/25 | 28.09 on 11/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 822,132 | 825,623 | 811,496 | ||
| Shares Outstanding, K | 85,372 | 138,064 | 54,536 | ||
| Annual Sales | 0 | 74,210,000 | 0 | ||
| Annual Net Income | -43,000,000 | -521,960,000 | -68,000,000 | ||
| Last Quarter Sales | 0 | 12,370,000 | 0 | ||
| Last Quarter Net Income | -12,110,000 | -104,590,000 | -20,960,000 | ||
| 60-Month Beta | 0.80 | 1.14 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 02/12/25 | -0.76 on 02/26/25 | -0.39 on 03/27/25 | ||
| Latest Earnings Date | 05/08/25 | 05/01/25 | 04/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||